Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation

被引:57
作者
Martens, N
Uzan, G
Wery, M
Hooghe, R
Hooghe-Peters, EL
Gertler, A
机构
[1] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel
[2] Univ Libre Brussels, Sch Med, Neuroendocrine Immunol & Pharmacol Dept, B-1090 Brussels, Belgium
[3] Fac Univ Notre Dame Paix, Mol Genet Lab, B-5000 Namur, Belgium
关键词
D O I
10.1074/jbc.M411596200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the role of one of the less studied members of the family of suppressors of cytokine signaling ( SOCS), namely SOCS-7, in cytokine signaling. We demonstrate that SOCS-7 inhibits prolactin (PRL), growth hormone (GH), or leptin (LEP) signaling mediated through STAT3 and STAT5 in a dose-dependent manner. SOCS-7 also attenuated STAT3 and STAT5 signaling induced by overexpression of JH1, the catalytic subdomain of JAK2. Since SOCS-7 interacted with phosphorylated STAT3 or STAT5, we assumed that SOCS-7 acts at the level of STAT proteins. Indeed, we showed that SOCS-7 inhibits PRL- and leptin-induced STAT5 and STAT3 phosphorylation and prevented the nuclear translocation of activated STAT3. Taken together, our results indicate that SOCS-7 is a physiological dysregulator of PRL, leptin, and probably also GH signaling and that its mode of action is a novel variation of SOCS protein inhibition of cytokine-inducible STAT-mediated signal transduction.
引用
收藏
页码:13817 / 13823
页数:7
相关论文
共 30 条
[1]   A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation [J].
Barber, DL ;
Beattie, BK ;
Mason, JM ;
Nguyen, MHH ;
Yoakim, M ;
Neel, BG ;
D'Andrea, AD ;
Frank, DA .
BLOOD, 2001, 97 (08) :2230-2237
[2]   Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling [J].
Bayle, J ;
Letard, B ;
Frank, R ;
Dubreuil, P ;
De Sepulveda, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12249-12259
[3]   Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins [J].
Ben-Yair, L ;
Slaaby, R ;
Herman, A ;
Cohen, Y ;
Biener, E ;
Moran, N ;
Yoshimura, A ;
Whittaker, J ;
De Meyts, P ;
Herman, B ;
Gertler, A .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (03) :456-464
[4]   Ovine placental lactogen-induced heterodimerization of ovine growth hormone and prolactin receptors in living cells is demonstrated by fluorescence resonance energy transfer nicroscopy and leads to prolonged phosphorylation of signal transducer and activator of transcription (STAT)1 and STAT3 [J].
Biener, E ;
Martin, C ;
Daniel, N ;
Frank, SJ ;
Centonze, VE ;
Herman, B ;
Djiane, J ;
Gertler, A .
ENDOCRINOLOGY, 2003, 144 (08) :3532-3540
[5]   Ontogenesis of leptin receptor in rat Leydig cells [J].
Caprio, M ;
Fabbrini, E ;
Ricci, G ;
Basciani, S ;
Gnessi, L ;
Arizzi, M ;
Carta, AR ;
De Martino, MU ;
Isidori, AM ;
Frajese, GV ;
Fabbri, A .
BIOLOGY OF REPRODUCTION, 2003, 68 (04) :1199-1207
[6]  
Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
[7]   Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines [J].
Dogusan, Z ;
Hooghe-Peters, EL ;
Berus, D ;
Velkeniers, B ;
Hooghe, R .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (01) :34-39
[8]   SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin [J].
Duan, CJ ;
Li, MH ;
Rui, LY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (42) :43684-43691
[9]  
Gietz RD, 2002, METHOD ENZYMOL, V350, P87
[10]   A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1) [J].
Giordanetto, F ;
Kroemer, RT .
PROTEIN ENGINEERING, 2003, 16 (02) :115-124